SCA

Clinical trials for SCA explained in plain language.

Never miss a new study

Get alerted when new SCA trials appear

Sign up with your email to follow new studies for SCA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental drug offered to rare neurological disorder patients

Disease control AVAILABLE

This program provides access to the investigational drug troriluzole for people with spinocerebellar ataxia (SCA), a rare genetic disorder that affects movement and coordination. The program is designed for patients who have a confirmed SCA diagnosis and may include both new pati…

Matched conditions: SCA

Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

SCA

Get alerted when new SCA trials appear

Experimental drug offered to rare neurological disorder patients